Expert Opinion on Pharmacotherapy

5.2k papers and 88.9k indexed citations i.

About

The 5.2k papers published in Expert Opinion on Pharmacotherapy in the last decades have received a total of 88.9k indexed citations. Papers published in Expert Opinion on Pharmacotherapy usually cover Surgery (800 papers), Pulmonary and Respiratory Medicine (770 papers) and Epidemiology (763 papers) specifically the topics of Diabetes Treatment and Management (272 papers), Asthma and respiratory diseases (181 papers) and Bipolar Disorder and Treatment (166 papers). The most active scholars publishing in Expert Opinion on Pharmacotherapy are Paul J. Goodnick, Steven R. Feldman, Vincent Soriano, Moses Elisaf and Sheila A Doggrell.

In The Last Decade

Fields of papers published in Expert Opinion on Pharmacotherapy

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers published in Expert Opinion on Pharmacotherapy. Nodes represent fields, and links connect fields that are likely to share authors.

Countries where authors publish in Expert Opinion on Pharmacotherapy

Since Specialization
Total citations of papers

This map shows the geographic distribution of research published in Expert Opinion on Pharmacotherapy. It shows the number of citations received by papers published by authors working in each country. You can also color the map by specialization and compare the number of papers published in Expert Opinion on Pharmacotherapy with the expected number of papers based on a country's size and research output (numbers larger than one mean the country's share of papers is larger than expected).

Rankless by CCL
2025